2015 APHA Annual Meeting & Expo

Home Events & Meetings Annual Meeting Schedule & Program

Recorded Annual Meeting Presentations (RAMP) are now available for purchase.
Only $90 for presenters, $140 for registered attendees and $200 for non-attendees.

Online Program

336996
Improving Women's Health Outcomes in Assisted Reproductive Technologies


Wednesday, November 4, 2015 : 1:00 p.m. - 1:15 p.m.

Susan Berke Fogel, JD, Pro-Choice Alliance for Responsible Research, Van Nuys, CA
Audio (mp3) recording Recorded Presentation (mp4)
Fertility clinics, brokers, and agencies operate in the United States with little oversight other than state licensing of medical providers and almost no oversight of brokers and agencies. The Centers for Disease Control and Prevention (CDC) are tasked with limited oversight of fertility clinics, however that oversight is comprised generally of tracking birth outcomes from assisted reproduction. The CDC tracking does not document the health outcomes for women who provide eggs for their own fertility or the fertility of others. Reporting that reflects only successful births may create inappropriate incentives to ignore women’s health outcomes. A recent Institute of Medicine report highlighted the lack of data on the health effects of assisted reproductive technologies (ARTs) on the women involved or the children born of ARTs. This presentation will provide an overview of federal and state laws that regulate fertility clinics, brokers, and agencies, and will explore strategies for increased data collection and accountability to improve health outcomes for women who participate in assisted reproductive technologies.

Learning Areas:

Advocacy for health and health education
Ethics, professional and legal requirements
Other professions or practice related to public health
Public health or related laws, regulations, standards, or guidelines

Learning Objectives:
Identify key legal and regulatory requirements and deficiencies in the oversight of fertility clinics, brokers, and agencies Formulate strategies to require accountability and improve health outcomes for women who participate in assisted reproductive technologies

Keyword(s): Reproductive Health, Advocacy

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am the co-founder of the Pro-Choice Alliance for Responsible Research. I am an attorney with significant experience in women's health, reproductive health, and assisted reproductive technologies. I have researched the laws and policies affecting reproductive health, and have written and presented on these issues, and previously taught Reproductive Health Advocacy at the UCLA School of Public Health.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

Back to: 5173.0: Assisted reproductive technologies